Literature DB >> 23465517

Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.

Anna Bill-Axelson1, Hans Garmo, Lars Holmberg, Jan-Erik Johansson, Hans-Olov Adami, Gunnar Steineck, Eva Johansson, Jennifer R Rider.   

Abstract

BACKGROUND: Studies enumerating the dynamics of physical and emotional symptoms following prostate cancer (PCa) treatment are needed to guide therapeutic strategy. Yet, overcoming patient selection forces is a formidable challenge for observational studies comparing treatment groups.
OBJECTIVE: To compare patterns of symptom burden and distress in men with localized PCa randomized to radical prostatectomy (RP) or watchful waiting (WW) and followed up longitudinally. DESIGN, SETTING, AND PARTICIPANTS: The three largest, Swedish, randomization centers for the Scandinavian Prostate Cancer Group-4 trial conducted a longitudinal study to assess symptoms and distress from several psychological and physical domains by mailed questionnaire every 6 mo for 2 yr and then yearly through 8 yr of follow-up. INTERVENTION: RP compared with WW. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: A questionnaire was mailed at baseline and then repeatedly during follow-up with questions concerning physical and mental symptoms. Each analysis of quality of life was based on a dichotomization of the outcome (yes vs no) studied in a binomial response, generalized linear mixed model. RESULTS AND LIMITATIONS: Of 347 randomized men, 272 completed at least five questionnaires during an 8-yr follow-up period. Almost all men reported that PCa negatively influenced daily activities and relationships. Health-related distress, worry, feeling low, and insomnia were consistently reported by approximately 30-40% in both groups. Men in the RP group consistently reported more leakage, impaired erection and libido, and fewer obstructive voiding symptoms. For men in the WW group, distress related to erectile symptoms increased gradually over time. Symptom burden and distress at baseline was predictive of long-term outlook.
CONCLUSIONS: Cancer negatively influenced daily activities among almost all men in both treatment groups; health-related distress was common. Trade-offs exist between physiologic symptoms, highlighting the importance of tailored treatment decision-making. Men who are likely to experience profound long-term distress can be identified early in disease management.
Copyright © 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Prostate cancer; Quality of life; Radical prostatectomy; Randomized; Watchful waiting

Mesh:

Year:  2013        PMID: 23465517     DOI: 10.1016/j.eururo.2013.02.025

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  28 in total

Review 1.  Diet and lifestyle considerations for patients with prostate cancer.

Authors:  Kyle B Zuniga; June M Chan; Charles J Ryan; Stacey A Kenfield
Journal:  Urol Oncol       Date:  2019-07-18       Impact factor: 3.498

2.  Radical prostatectomy versus deferred treatment for localised prostate cancer.

Authors:  Robin Wm Vernooij; Michelle Lancee; Anne Cleves; Philipp Dahm; Chris H Bangma; Katja Kh Aben
Journal:  Cochrane Database Syst Rev       Date:  2020-06-04

3.  Factors associated with emotional distress in newly diagnosed prostate cancer patients.

Authors:  Heather Orom; Christian J Nelson; Willie Underwood; D Lynn Homish; Deepak A Kapoor
Journal:  Psychooncology       Date:  2015-01-28       Impact factor: 3.894

4.  Toward ethically responsible choice architecture in prostate cancer treatment decision-making.

Authors:  J S Blumenthal-Barby; Denise Lee; Robert J Volk
Journal:  CA Cancer J Clin       Date:  2015-05-21       Impact factor: 508.702

5.  Worse Urinary, Sexual and Bowel Function Cause Emotional Distress and Vice Versa in Men Treated for Prostate Cancer.

Authors:  Heather Orom; Caitlin Biddle; Willie Underwood; Christian J Nelson
Journal:  J Urol       Date:  2017-12-26       Impact factor: 7.450

6.  Functional outcomes of robot-assisted radical prostatectomy in patients eligible for active surveillance.

Authors:  Marc Zanaty; Khaled Ajib; Kevin Zorn; Assaad El-Hakim
Journal:  World J Urol       Date:  2018-04-21       Impact factor: 4.226

Review 7.  Active surveillance in men with low-risk prostate cancer: current and future challenges.

Authors:  Christopher Sejong Han; Jaspreet Singh Parihar; Isaac Yi Kim
Journal:  Am J Clin Exp Urol       Date:  2013-12-25

8.  Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.

Authors:  J L Donovan; F C Hamdy; J A Lane; D E Neal; M Mason; C Metcalfe; E Walsh; J M Blazeby; T J Peters; P Holding; S Bonnington; T Lennon; L Bradshaw; D Cooper; P Herbert; J Howson; A Jones; N Lyons; E Salter; P Thompson; S Tidball; J Blaikie; C Gray; P Bollina; J Catto; A Doble; A Doherty; D Gillatt; R Kockelbergh; H Kynaston; A Paul; P Powell; S Prescott; D J Rosario; E Rowe; M Davis; E L Turner; R M Martin
Journal:  N Engl J Med       Date:  2016-09-14       Impact factor: 91.245

9.  Radical prostatectomy or watchful waiting in early prostate cancer.

Authors:  Anna Bill-Axelson; Lars Holmberg; Hans Garmo; Jennifer R Rider; Kimmo Taari; Christer Busch; Stig Nordling; Michael Häggman; Swen-Olof Andersson; Anders Spångberg; Ove Andrén; Juni Palmgren; Gunnar Steineck; Hans-Olov Adami; Jan-Erik Johansson
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

Review 10.  All change in the prostate cancer diagnostic pathway.

Authors:  Derek J Lomas; Hashim U Ahmed
Journal:  Nat Rev Clin Oncol       Date:  2020-02-28       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.